Literature DB >> 21352524

Acute myopathy secondary to oral steroid therapy in a 49-year-old man: a case report.

Muhammad A Khan1, Eric Larson.   

Abstract

INTRODUCTION: Acute myopathy caused by oral corticosteroids is rare. We present a case of myopathy occurring after two doses of methylprednisolone. Typically, acute steroid myopathy occurs with therapy using intravenous corticosteroids at high doses. Acute myopathy developing very early in the course of treatment with oral corticosteroids has been reported only once in the literature. Corticosteroid therapy may be complicated by myopathy, usually chronic, after prolonged high-dose therapy. Acute myopathy caused by exogenous corticosteroids is rare, usually with intravenous corticosteroids at high doses. CASE
PRESENTATION: A 49-year-old Caucasian man developed acute myopathy after taking oral methylprednisolone for only two days, 24 mg on day 1 and 20 mg on day 2. He discontinued the medication because of new-onset myalgias and lethargy on day 3 and was seen in our clinic four days after beginning therapy. He completely recovered in four weeks by discontinuing the corticosteroids.
CONCLUSION: Among the many complications of corticosteroid therapy, acute myopathy is very rare. It requires prompt recognition and adjustment of therapy.

Entities:  

Year:  2011        PMID: 21352524      PMCID: PMC3055833          DOI: 10.1186/1752-1947-5-82

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  10 in total

1.  Corticosteroid myopathy.

Authors:  D N GOLDING; S M MURRAY; G W PEARCE; M THOMPSON
Journal:  Ann Phys Med       Date:  1961-11

2.  Triamcinolone in the treatment of systemic lupus erythematosus.

Authors:  E L DUBOIS
Journal:  J Am Med Assoc       Date:  1958-07-26

3.  Acute corticosteroid myopathy in intensive care patients.

Authors:  P Hanson; A Dive; J M Brucher; M Bisteau; M Dangoisse; T Deltombe
Journal:  Muscle Nerve       Date:  1997-11       Impact factor: 3.217

Review 4.  Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway.

Authors:  W E Mitch; A L Goldberg
Journal:  N Engl J Med       Date:  1996-12-19       Impact factor: 91.245

5.  Enzyme elevation in patients with juvenile dermatomyositis and steroid myopathy.

Authors:  Maryam Y Naim; Ann M Reed
Journal:  J Rheumatol       Date:  2006-07       Impact factor: 4.666

6.  Severe myopathy after status asthmaticus.

Authors:  I A MacFarlane; F D Rosenthal
Journal:  Lancet       Date:  1977-09-17       Impact factor: 79.321

7.  Acute hydrocortisone myopathy.

Authors:  W Van Marle; K L Woods
Journal:  Br Med J       Date:  1980-07-26

8.  Dexamethasone inhibits insulin-like growth factor signaling and potentiates myoblast apoptosis.

Authors:  J R Singleton; B L Baker; A Thorburn
Journal:  Endocrinology       Date:  2000-08       Impact factor: 4.736

9.  Steroid myopathy in connective tissue disease.

Authors:  A Askari; P J Vignos; R W Moskowitz
Journal:  Am J Med       Date:  1976-10       Impact factor: 4.965

10.  Steroid-induced myopathy following a single oral dose of prednisolone.

Authors:  S Kumar
Journal:  Neurol India       Date:  2003-12       Impact factor: 2.117

  10 in total
  2 in total

1.  Acute myopathy following intra-muscular injection of compound betamethasone: A case report.

Authors:  Li-Yuan Sun; Xiao-Ling Chu
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

2.  Possible exercised-induced rhabdomyolysis associated with terbinafine.

Authors:  Peter V Bui; Gregory Gafni-Pappas
Journal:  Oxf Med Case Reports       Date:  2019-05-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.